Chemed Corp. Q1 2002 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2002 for Chemed Corporation, a Delaware corporation headquartered in Cincinnati, Ohio. The company operates primarily through three segments: Roto-Rooter (plumbing and drain cleaning), Patient Care (home health services), and Service America (pest control and related services). As of April 30, 2002, there were 9,790,902 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Service Revenues and Sales | $117.0 million | $121.2 million |
| Net Income | $4.7 million | $4.5 million |
| Earnings Per Share (Diluted) | $0.47 | $0.46 |
| Operating Income | $5.7 million | $7.5 million |
| Operating Margin | 4.9% | 6.2% |
| Net Cash from Operating Activities | $5.9 million | $10.0 million |
| Cash and Cash Equivalents | $14.6 million | $14.9 million |
| Total Debt (Current + Long-term) | $66.3 million | $61.4 million |
| Unused Credit Lines | $18.5 million | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 3% year-over-year. The Roto-Rooter segment saw a 5% decline due to lower plumbing and drain cleaning volumes. Service America revenues dropped 13% due to fewer contract renewals and the divestment of a Tucson branch. Patient Care revenues increased 4%.
- Profitability: While reported Net Income increased slightly, Adjusted Net Income (excluding 2001 goodwill amortization) declined significantly from $5.7 million in Q1 2001 to $4.7 million in Q1 2002. This reflects a drop in operating income driven by higher labor costs in the Roto-Rooter segment and operating leverage issues in Service America.
- Interest Expense: Interest expense decreased 48% to $0.8 million, attributed to refinancing long-term debt at lower rates in late 2001.
- Cash Flow: Net cash provided by operating activities fell 41% to $5.9 million, primarily due to a decrease in accounts payable and other current liabilities compared to the prior year.
Outlook, Risks, and Unusual Items
- Pending Sale of Patient Care: On May 8, 2002, Chemed announced an agreement to sell its Patient Care subsidiary for approximately $70 million in cash. The company expects to recognize an after-tax loss of $1 to $2 million on the transaction. Closing is contingent on regulatory approvals and financing commitments by June 30, 2002.
- Accounting Changes: The company adopted SFAS No. 142 effective January 1, 2002, which eliminated the amortization of goodwill. Preliminary impairment tests indicate no goodwill impairment as of January 1, 2002.
- Liquidity: Management considers liquidity satisfactory, with $14.6 million in cash and $18.5 million in unused credit lines available.
- Risks: Forward-looking statements are subject to risks including regulatory approvals for the Patient Care sale, market conditions affecting service demand, and the ability to secure financing for the sale.
Investor Verification Checklist
- Verify the closing status and final proceeds of the Patient Care subsidiary sale.
- Monitor the impact of the Patient Care divestiture on future revenue and earnings guidance.
- Review the completion of the goodwill impairment testing required by SFAS No. 142 (due by June 30, 2002).
- Assess the sustainability of the Roto-Rooter segment's margin compression due to rising labor costs.
- Confirm the utilization of the $18.5 million in unused credit lines and future debt repayment plans using sale proceeds.